Compliance & Validation — Not documented by Atlas
Ask the vendor: Which compliance certifications (HIPAA, 21 CFR Part 11, SOC 2, GxP) do you hold?
Developer of safety-focused generative AI healthcare agents for non-diagnostic, patient-facing tasks.
Hippocratic AI, founded in 2023 and headquartered in Palo Alto, California, develops generative AI voice agents for non-diagnostic, patient-facing healthcare tasks such as appointment outreach, medication reminders, and care program check-ins, with a staged safety-testing approach involving licensed clinicians. The company reports HITRUST e1 certification for its agentic platform and serves providers, payors, and pharmaceutical organizations. It is not a validated GxP system, and its clinical-safety claims should be evaluated directly with the vendor. The company raised a $126 million Series C in November 2025, bringing total funding to roughly $404 million, and acquired Grove AI in January 2026.
43% — Partial coverage. Coverage score — how completely Atlas documents Hippocratic AI across 7 buyer-evaluation areas. Reflects available Atlas data, not solution quality.
Ask the vendor: Which compliance certifications (HIPAA, 21 CFR Part 11, SOC 2, GxP) do you hold?
cloud
Ask the vendor: What is your pricing model, and what drives total cost of ownership?
Ask the vendor: What is a realistic implementation timeline, and what onboarding support is included?
Large Pharma, Top 20 Pharma, Medical Affairs, Clinical Operations
Generative AI & LLMs
Series C, $404M raised, Founded 2023
Not captured in Atlas data — confirm directly. Excluded from the score above.
Who owns model outputs? Is our proprietary data used to train models others can access, and where does our data reside?
Can you share validation studies or benchmarks, explain how the model reaches its conclusions, and describe how bias and drift are monitored?